The global Antimicrobial Catheter Market consists of devices intended for short- or long-term urinary catheterization. Antimicrobial catheters prevent the risk of hospital-acquired or nosocomial urinary tract infections by releasing antimicrobial agents to reduce bacteria colonization. The global Antimicrobial Catheter Market is estimated to be valued at US$ 14505.18 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing prevalence of hospital-acquired infections
The key trend fueling the growth of the antimicrobial catheter market is the increasing prevalence of hospital-acquired or nosocomial infections. Hospital-acquired infections refer to infections that patients acquire during the course of treatment for medical or surgical conditions. According to the Centers for Disease Control and Prevention (CDC), over 2 million patients in the U.S. develop hospital-acquired infections each year, leading to around 99,000 associated deaths. Urinary tract infections are among the most common types of hospital-acquired infections, caused majorly due to prolonged use of urinary catheters in hospitals. This has generated a dire need to use antimicrobial catheters releasing antibiotics to reduce infection risk.
Strength: Antimicrobial catheters help prevent hospital-acquired infections, reducing treatment costs and hospital stays. They are more effective than traditional catheters at fighting infections.
Weakness: Higher costs than conventional catheters can be a budgetary concern for some healthcare providers and patients. Availability of cheaper substitutes may also affect market growth.
Opportunity: Growing geriatric population and rising prevalence of chronic diseases increase the patient pool needing long-term catheterization, driving market opportunities.
Threats: Stringent regulatory environment and lengthy approval process pose challenges. Supply chain disruptions due to COVID-19 have also impacted market revenues.
The Global Antimicrobial Catheter Market Size is expected to witness high growth.
North America currently dominates the market owing to rising healthcare spending and presence of major players. The Asia Pacific region is projected to grow at the fastest pace during the forecast period due to improving access to healthcare and growing medical tourism industry.
Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Wincole Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. These players are focusing on new product launches and enhancing geographical presence to strengthen their market position. For instance, in 2022 Amsterdam Wincole Probiotics launched Probio-Cat 2 catheter coated with prebiotic and probiotic blend to prevent catheter-associated urinary tract infections.